Plain-English translation of NCT07066046 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether using artificial intelligence during colonoscopy — a common screening procedure to check your colon — helps doctors find more problematic growths and lesions earlier. Researchers want to know if an AI system that analyzes the images in real-time can improve detection compared to standard colonoscopy without computer assistance. This could help prevent colorectal cancer by catching pre-cancerous changes before they develop.
Colorectal cancer is one of the most common cancers worldwide and a leading cause of cancer death. Colonoscopy is the best screening tool we have, but doctors sometimes miss small growths. Even small improvements in finding these growths early can significantly reduce deaths from this cancer. This trial exists to see if artificial intelligence can help doctors catch more of these lesions that might otherwise be missed.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either a standard colonoscopy or a colonoscopy assisted by artificial intelligence. The study is designed so doctors won't know which version you're receiving (to keep results fair), and you'll be grouped by age. The procedure itself works the same way — a thin tube with a camera is gently guided through your colon to look for any abnormal growths or lesions. The main difference is whether an AI system is helping analyze the images in real-time.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
Brazil
Sponsor
Instituto do Cancer do Estado de São Paulo
Enrollment target
~1,000 participants
Started
February 2025
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Márcio Roberto Facanali Júnior
Instituto do Cancer do Estado de São Paulo
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.